PROCEPT BioRobotics Corporation Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount
PROCEPT BioRobotics Corporation (PRCT) reported Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount of $26.80 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-26.
Financial Statements › Notes › Income Taxes › Components of Deferred Tax Assets and Liabilities › Components of Deferred Tax Assets
us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount · last filed 2026-02-26
- PROCEPT BioRobotics Corporation valuation allowance, deferred tax asset, increase (decrease), amount for fiscal 2025 was $26.80M, a 22.77% decline from fiscal 2024.
- PROCEPT BioRobotics Corporation valuation allowance, deferred tax asset, increase (decrease), amount for fiscal 2024 was $34.70M, a 26.64% increase from fiscal 2023.
- PROCEPT BioRobotics Corporation valuation allowance, deferred tax asset, increase (decrease), amount for fiscal 2023 was $27.40M, a 71.25% increase from fiscal 2022.
- PROCEPT BioRobotics Corporation valuation allowance, deferred tax asset, increase (decrease), amount for fiscal 2022 was $16.00M, a 0.00% change from fiscal 2021.
| Period end | Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount 12 month | Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount 12 month as first filed |
|---|---|---|
| 2025-12-31 | $26.80M 10-K · filed 2026-02-26 | |
| 2024-12-31 | $34.70M 10-K · filed 2026-02-26 | |
| 2023-12-31 | $27.40M 10-K · filed 2026-02-26 | |
| 2022-12-31 | $16.00M 10-K · filed 2025-02-27 | $26.00M 10-K · filed 2023-02-28 |
| 2021-12-31 | $16.00M 10-K · filed 2022-03-22 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Beta Bionics, Inc. (BBNX) | United States | $0.979B | -9.66 |
| TANDEM DIABETES CARE INC (TNDM) | United States | $1.059B | -16.57 |
| SpyGlass Pharma, Inc. (SGP) | United States | $0.925B | |
| IRADIMED CORP (IRMD) | United States | $1.089B | 52.92 |
| ARTIVION, INC. (AORT) | United States | $1.123B | -345.09 |
| SI-BONE, Inc. (SIBN) | United States | $0.830B | -49.82 |
| INTEGRA LIFESCIENCES HOLDINGS CORP (IART) | United States | $1.234B | -193.02 |
| MIMEDX GROUP, INC. (MDXG) | United States | $0.687B | 89.92 |
| ANGIODYNAMICS INC (ANGO) | United States | $0.632B | -13.02 |
| ORTHOPEDIATRICS CORP (KIDS) | United States | $0.592B |